Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 64.50 (+2.46%)
Disc Medicine Reports Positive Phase 1b Results for DISC-0974 in Myelofibrosis Anemia and Initiates Phase 2 Study

Disc Medicine's DISC-0974 shows positive hematologic responses in myelofibrosis anemia, leading to a Phase 2 trial initiation.Quiver AI SummaryDisc Medicine, Inc. announced positive results from a Phase...

IRON : 64.50 (+2.46%)
Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 64.50 (+2.46%)
Insider Sale: Director at $IRON (IRON) Sells 173 Shares

William Richard White, a director at $IRON ($IRON), sold 173 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their...

IRON : 64.50 (+2.46%)
Insider Sale: Chief Medical Officer of $IRON (IRON) Sells 1,904 Shares

William Jacob Savage, the Chief Medical Officer of $IRON ($IRON), sold 1,904 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

IRON : 64.50 (+2.46%)
Disc Medicine to Participate in Upcoming Investor Conferences

IRON : 64.50 (+2.46%)
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

IRON : 64.50 (+2.46%)
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

IRON : 64.50 (+2.46%)
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 64.50 (+2.46%)
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

IRON : 64.50 (+2.46%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025?
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar